Product
Cabotegravir/Rilpivirine
2 clinical trials
2 indications
Indication
HIVIndication
HIV-1 infectionClinical trial
Project Tara: Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social NeedsStatus: Not yet recruiting, Estimated PCD: 2025-05-30
Clinical trial
A Phase 3b Randomised, Multicentre, Open-label Study Evaluating the Effectiveness of Switching to Two-monthly Long-acting Injectable Cabotegravir and Rilpivirine From First-line Oral Antiretroviral Therapy in HIV-1 Positive Virologically Suppressed Adults With a History of, or at Risk of, Sub-optimal HIV Control in Sub-Saharan AfricaStatus: Recruiting, Estimated PCD: 2024-11-01